N-acetylcysteine and Hydroxychloroquine Ameliorate ADMA-Induced Fetal Growth Restriction in Mice via Regulating Oxidative Stress and Autophagy

© 2023. The Author(s), under exclusive licence to Society for Reproductive Investigation..

Fetal growth restriction (FGR) seriously threatens perinatal health. The main cause of FGR is placental malperfusion, but the specific mechanism is still unclear, and there is no effective treatment for FGR. We constructed a FGR mouse model by adding exogenous asymmetric dimethylarginine (ADMA) through in vivo experiments and found that ADMA could cause placental dysplasia and induce the occurrence of FGR. Compared with the control group, reactive oxygen species (ROS) production in the placenta was increased in mice with FGR, and the expression of autophagy-related proteins p-AKT/AKT, p-mTOR/mTOR, and P62 was significantly decreased, while the expression of Beclin-1 and LC3-II was significantly increased in the FGR group. Furthermore, ADMA had a favorable effect in promoting the formation of autophagosomes. Hydroxychloroquine (HCQ) and N-acetylcysteine (NAC) improved ADMA-induced disorders of placental development and alleviated ADMA-induced FGR. This study found that ADMA could cause excessive autophagy of trophoblasts by increasing the level of oxidative stress, ultimately leading to the occurrence of FGR, and HCQ and NAC had therapeutic effects on ADMA-induced FGR.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:31

Enthalten in:

Reproductive sciences (Thousand Oaks, Calif.) - 31(2024), 3 vom: 04. März, Seite 779-790

Sprache:

Englisch

Beteiligte Personen:

Dai, Yan [VerfasserIn]
Sang, Xiu-Bo [VerfasserIn]
Bai, Wen-Pei [VerfasserIn]

Links:

Volltext

Themen:

4QWG6N8QKH
63CV1GEK3Y
94ZLA3W45F
Acetylcysteine
Arginine
Asymmetric dimethylarginine
Autophagy
EC 2.7.11.1
Fetal growth restriction
Hydroxychloroquine
Journal Article
N,N-dimethylarginine
N-acetylcysteine
Oxidative stress
Proto-Oncogene Proteins c-akt
TOR Serine-Threonine Kinases
WYQ7N0BPYC

Anmerkungen:

Date Completed 06.03.2024

Date Revised 06.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s43032-023-01380-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363383514